Pulmonary thrombo-embolism in pregnancy: Diagnosis and management

Breathe

Volumn 11, Issue 4, 2015, Pages 282-289

  Simcox, Louise E ^a,b   Ormesher, Laura ^b   Tower, Clare ^a,b   Greer, Ian A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; DEEP VEIN THROMBOSIS; DELIVERY; HUMAN; LABOR; LUNG ANGIOGRAPHY; LUNG EMBOLISM; NOTE; PREGNANCY DISORDER; PREVALENCE; PUERPERIUM; RISK FACTOR; THORAX RADIOGRAPHY; THROMBOSIS PREVENTION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 84955155546     PISSN: 18106838     EISSN: 20734735     Source Type: Journal    
DOI: 10.1183/20734735.008815     Document Type: Note

References (43)

1. Knight M, Kenyon S, Brocklehurst P, et al. Eds. on behalf UK and Ireland Confidential Enquiries into Maternal Deaths of MBRRACE-UK. Saving Lives, Improving Mothers’ Care- and Morbidity 2009-12. Oxford, University of Oxford, Lessons learned to inform future maternity care from the 2014.
2. Nelson-Piercy C, MacCallum P, Mackillop L. Green-top Guideline No. 37a - reducing the risk of venous thromboem-bolism during pregnancy and the puerperium. London, Royal College of Obstetricians and Gynaecologists, 2015.
3. Chan WS, Ray JG, Murray S, et al. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 2002; 162: 1170-1175.
4. Shahir K, Goodman LR, Tali A, et al. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning. AJR Am J Roentgenol 2010; 195: W214-W220.
5. Ramsay R, Byrd L, Tower C, et al. The problem of pulmonary embolism diagnosis in pregnancy. Br J Haematol 2015; 170: 727-728.
6. Greer I, Thomson AJ. Green-top Guideline No. 37b - throm- boembolic disease in pregnancy and the puerperium: acute management. London, Royal College of Obstetricians and Gynaecologists, 2015.
7. Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: Suppl, 2 e691S-e736S.
8. Knight M, Ukoss. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 2008; 115: 453-461.
9. Andersen BS, Steffensen FH, Sorensen HT, et al. The cumulative incidence of venous thromboembolism during preg- nancy and puerperium-an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77: 170-173.
10. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
11. White RH. The epidemiology of venous thromboem- bolism. Circulation 2003; 107: 23 Suppl 1, I4-I8.
12. Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy. Lancet 2010; 375: 500-512.
13. Gherman RB, Goodwin TM, Leung B, et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 730-734.
14. James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194: 1311-1315.
15. Greer IA. Thrombosis in pregnancy: updates in diag- nosis and management. Hematology (Am Soc Hematol Educ Program) 2012; 2012: 203-207.
16. Kamel H, Navi BB, Sriram N, et al. Risk of a throm- botic event after the 6-week postpartum period. N Engl J Med 2014; 370: 1307-1315.
17. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol 2008; 198: 233 e1-e7.
18. Nelson-Piercy C. Handbook of Obstetric Medicine. 4th Edn. London, Informa UK Ltd, 2010. 19.
19. Carson JL, Kelley MA, Duff A, et al. The clinical course of pul- monary embolism. N Engl J Med 1992; 326: 1240-1245.
20. Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary embolism in pregnancy. Obstet Gynecol Clin North Am 1991; 18: 345-370.
21. Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evi- dence-Based Clinical Practice Guidelines. Chest 2012; 141: 2 Suppl, e351S-e418S
22. Khalafallah AA, Morse M, Al-Barzan AM, et al. D-Di- mer levels at different stages of pregnancy in Australian women: a single centre study using two different immuno- turbidimetric assays. Thromb Res 2012; 130: e171-e177.
23. To MS, Hunt BJ, Nelson-Piercy C. A negative D-dimer does not exclude venous thromboembolism (VTE) in preg- nancy. J Obstet Gynaecol Res 2008; 28: 222-223.
24. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135: 98-107.
25. Righini M, Jobic C, Boehlen F, et al. Predicting deep venous thrombosis in pregnancy: external validation of the LEFT clinical prediction rule. Haematologica 2013; 98: 545-548.
26. Rodger MA, Le Gal G, Wells P, et al. Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities. Thromb Res 2014; 134: 763-768.
27. Blanco-Molina A, Rota LL, Di Micco P, et al. Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb Haemost 2010; 103: 306-311.
28. Fidler JL, Patz EF Jr, Ravin CE. Cardiopulmonary complications of pregnancy: radiographic findings. AJR Am J Roentgenol 1993; 161: 937-942.
29. Daftary A, Gregory M, Daftary A, et al. Chest radio- graph as a triage tool in the imaging-based diagnosis of pulmonary embolism. AJR Am J Roentgenol 2005; 185: 132-134.
30. Eskandar OS, Eckford SD, Watkinson T. Safety of diag- nostic imaging in pregnancy. Part 1: X-ray, nuclear medicine investigations, computed tomography and contrast media. Obstet Gynaecol 2010; 12: 71-78.
31. Remy-Jardin M, Remy J. Spiral CT angiography of the pulmonary circulation. Radiology 1999; 212: 615-636.
32. Hurwitz LM, Yoshizumi TT, Goodman PC, et al. Radiation dose savings for adult pulmonary embolus 64-MDCT using bismuth breast shields, lower peak kilovoltage, and automatic tube current modulation. AJR Am J Roentgenol 2009; 192: 244-253.
33. Schembri GP, Miller AE, Smart R. Radiation dosime- try and safety issues in the investigation of pulmonary embolism. Semin Nucl Med 2010; 40: 442-454.
34. Bourjeily G, Chalhoub M, Phornphutkul C, et al. Neonatal thy- roid function: effect of a single exposure to iodinated contrast medium in utero. Radiology 2010; 256: 744-750.
35. Scarsbrook AF, Evans AL, Owen AR, et al. Diagnosis of suspected venous thromboembolic disease in pregnancy. Clin Radiol 2006; 61: 1-12.
36. Ridge CA, McDermott S, Freyne BJ, et al. Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. AJR Am J Roentgenol 2009; 193: 1223-1227.
37. Gould MK, Dembitzer AD, Doyle RL, et al. Low-mo- lecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130: 800-809.
38. Quinlan DJ, McQuillan A, Eikelboom JW. Low-mo- lecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004; 140: 175-183.
39. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401-407.
40. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 1 Suppl, 64S-94S.
41. Patel JP, Green B, Patel RK, et al. Population pharma- cokinetics of enoxaparin during the antenatal period. Circulation 2013; 128: 1462-1469.
42. Kahn SR, Shapiro S, Wells PS, et al. SOX trial inves- tigators. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 2014; 383: 880-888.
43. Limmer JS, Grotegut CA, Thames E, et al. Postpartum wound and bleeding complications in women who received peripartum anticoagulation. Thromb Res 2013; 132: e19-e23